Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production

Annals of Thoracic Surgery

Volumn 79, Issue 3, 2005, Pages 917-923

  Lappegård, Knut Tore ^a   Riesenfeld, Johan ^b   Brekke, Ole Lars ^b   Bergseth, Grethe ^b   Lambris, John D ^b   Mollnes, Tom Eirik ^b  

^a NORDLAND HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; COMPSTATIN; HEPARIN; ICOSANOID; INDOMETACIN; LEUKOTRIENE B4; LIPOXYGENASE; PEPTIDE; POLYVINYLCHLORIDE; PROSTAGLANDIN E2; THROMBOXANE B2; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; BLOOD; BLOOD CHEMISTRY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; ENZYME ANALYSIS; FATTY ACID SYNTHESIS; HUMAN; ICOSANOID METABOLISM; INFLAMMATION; MATERIAL COATING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; SURFACE PROPERTY;

EID: 14244263332     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.08.015     Document Type: Article

References (40)

1. J.H. Levy, K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 2003 S715 S720
2. L.H. Edmunds Jr Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 66 1998 S12 S16
3. P. Olsson, J. Sanchez, T.E. Mollnes, J. Riesenfeld On the blood compatibility of end-point immobilized heparin J Biomater Sci Polym Ed 11 2000 1261 1273
4. L.C. Hsu Heparin-coated cardiopulmonary bypass circuits: current status Perfusion 16 2001 417 428
5. V. Videm, T.E. Mollnes, K. Bergh Heparin-coated cardiopulmonary bypass equipment II Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg 117 1999 803 809
6. J.C. Fitch, S. Rollins, L. Matis Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass Circulation 100 1999 2499 2506
7. A. Undar, H.C. Eichstaedt, F.J. Clubb Jr Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass Ann Thorac Surg 74 2002 355 362
8. K.T. Lappegård, M. Fung, G. Bergseth Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation Ann Thorac Surg 77 2004 932 941
9. K.T. Lappegård, M. Fung, G. Bergseth, J. Riesenfeld, T.E. Mollnes Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition Ann Thorac Surg 78 2004 38 44
10. R.L. Korn, C.A. Fisher, E.R. Livingston The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation J Thorac Cardiovasc Surg 111 1996 1073 1084
11. N. Hatori, H. Yoshizu, Y. Haga Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass Artif Organs 18 1994 904 910
12. A.B. Nichols, J. Owen, B.A. Grossman, J.J. Marcella, L.N. Fleisher, M.M. Lee Effect of heparin bonding on catheter-induced fibrin formation and platelet activation Circulation 70 1984 843 850
13. Y. Yoshikai Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection Curr Opin Infect Dis 14 2001 257 263
14. C.A. Kontogiorgis, D.J. Hadjipavlou-Litina Non steroidal anti-inflammatory and anti-allergy agents Curr Med Chem 9 2002 89 98
15. A.M. Finch, A.K. Wong, N.J. Paczkowski Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a J Med Chem 42 1999 1965 1974
16. D. Mastellos, J.C. Papadimitriou, S. Franchini, P.A. Tsonis, J.D. Lambris A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration J Immunol 166 2001 2479 2486
17. Mallik B, Spruce L, Katragadda M, Carafides C, Morikis D, Lambris JD. Design and characterization of active hybrid peptide-peptidomimetic analogs of compstatin. Manuscript in preparation 2004.
18. A. Sahu, B.K. Kay, J.D. Lambris Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library J Immunol 157 1996 884 891
19. D. Morikis, A.M. Soulika, B. Mallik, J.L. Klepeis, C.A. Floudas, J.D. Lambris Improvement of the anti-C3 activity of compstatin using rational and combinatorial approaches Biochem Soc Trans 32 2004 28 32
20. T.E. Mollnes, J. Riesenfeld, P. Garred A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin Artif Organs 19 1995 909 917
21. T.E. Mollnes, O.L. Brekke, M. Fung Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation Blood 100 2002 1869 1877
22. T.E. Mollnes, T. Lea, S.S. Froland, M. Harboe Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex Scand J Immunol 22 1985 197 202
23. V. Videm, J.L. Svennevig, E. Fosse, G. Semb, A. Osterud, T.E. Mollnes Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
24. Y.T. Wachtfogel, P.C. Harpel, L.H. Edmunds Jr, R.W. Colman Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass Blood 73 1989 468 471
25. E.E. Caldwell, A.M. Andreasen, M.A. Blietz Heparin binding and augmentation of C1 inhibitor activity Arch Biochem Biophys 361 1999 215 222
26. J. Sanchez, G. Elgue, J. Riesenfeld, P. Olsson Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence J Biomed Mater Res 29 1995 655 661
27. O. Levy, R.M. Jean-Jacques, C. Cywes Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release Infect Immun 71 2003 6344 6353
28. M. Jormalainen, A.E. Vento, U. Wartiovaara-Kautto, R. Suojaranta-Ylinen, O.J. Ramo, J. Petaja Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model J Thorac Cardiovasc Surg 128 2004 189 196
29. R. Solberg, T. Scholz, V. Videm, C. Okkenhaug, A.O. Aasen Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation Transpl Int 11 1998 252 258
30. T. Takano, A.V. Cybulsky, X. Yang, L. Aoudjit Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells Am J Physiol Renal Physiol 281 2001 F841 F850
31. S.W. Crooks, R.A. Stockley Leukotriene B4 Int J Biochem Cell Biol 30 1998 173 178
32. S. Marleau, B. Fruteau de Laclos, A.B. Sanchez, P.E. Poubelle, P. Borgeat Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit J Immunol 163 1999 3449 3458
33. P. Marder, J.S. Sawyer, L.L. Froelich, L.L. Mann, S.M. Spaethe Blockade of human neutrophil activation by 2-2[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)- 5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist Biochem Pharmacol 49 1995 1683 1690
34. N.A. Pawlowski, E. Abraham, A. Hamill, W.A. Scott The cyclooxygenase and lipoxygenase activities of platelet-depleted human monocytes J Allergy Clin Immunol 74 1984 324 330
35. H.E. Claesson, U. Lundberg, C. Malmsten Serum-coated zymosan stimulates the synthesis of leukotriene B4 in human polymorphonuclear leukocytes Inhibition by cyclic AMP Biochem Biophys Res Commun 99 1981 1230 1237
36. M. Minkes, N. Stanford, M.M. Chi Cyclic adenosine 3′,5′- monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions J Clin Invest 59 1977 449 454
37. M.S. Kennedy, J.D. Stobo, M.E. Goldyne In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells Prostaglandins 20 1980 135 145
38. J.M. Schroder The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate J Exp Med 170 1989 847 863
39. E. Øvrum, G. Tangen, S. Tølløfsrud, M.A. Ringdal Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures Ann Thorac Surg 76 2003 1144 1148
40. S. Svenmarker, S. Haggmark, E. Jansson Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome Scand Cardiovasc J 36 2002 241 246